Advances in Cancer Chemotherapy publishes high-impact research and reviews focused on the development, optimization, and clinical application of chemotherapeutic strategies for cancer treatment. The journal highlights innovative approaches in cytotoxic and targeted therapies, drug resistance mechanisms, combination regimens, and personalized medicine. It covers topics such as molecular oncology, pharmacodynamics, drug delivery systems, immunochemotherapy, biomarkers for treatment response, and toxicity management. Serving as a platform for oncologists, pharmacologists, and cancer researchers, the journal encourages contributions that explore novel compounds, clinical trial findings, preclinical models, and translational studies. By bridging the gap between laboratory research and clinical practice, Advances in Cancer Chemotherapy aims to accelerate progress toward more effective, patient-centered cancer therapies.